|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
144,920,000 |
Market
Cap: |
30.56(B) |
Last
Volume: |
718,090 |
Avg
Vol: |
722,028 |
52
Week Range: |
$134.65 - $225.35 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 400 MIDCAP |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 516 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile ResMed is a holding company. Through its subsidiaries, Co. is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep-disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Co. operates in two segments: Sleep and Respiratory Care, which relates primarily to the sale of its products that are therapy-based equipment; and Software as a Service, which relates to the provision of software access with ongoing support and maintenance services as well as services such as training and consulting.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
43,511 |
54,727 |
95,405 |
308,624 |
Total Sell Value |
$9,282,873 |
$11,329,537 |
$18,545,846 |
$66,312,345 |
Total People Sold |
4 |
6 |
8 |
11 |
Total Sell Transactions |
6 |
9 |
24 |
75 |
End Date |
2024-03-14 |
2023-12-12 |
2023-06-13 |
2022-06-13 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Douglas Robert Andrew |
President and COO ResMed Inc. |
|
2019-05-15 |
4 |
AS |
$111.35 |
$368,234 |
D/D |
(3,307) |
45,414 |
|
- |
|
Douglas Robert Andrew |
President and COO ResMed Inc. |
|
2019-05-15 |
4 |
OE |
$43.63 |
$144,284 |
D/D |
3,307 |
48,721 |
|
- |
|
Farrell Michael J. |
Chief Executive Officer |
|
2019-05-13 |
4 |
AS |
$109.70 |
$729,751 |
D/D |
(6,651) |
286,337 |
|
- |
|
Farrell Michael J. |
Chief Executive Officer |
|
2019-05-13 |
4 |
OE |
$43.63 |
$290,183 |
D/D |
6,651 |
292,988 |
|
- |
|
Pendarvis David |
Chief Administrative Officer |
|
2019-05-03 |
4 |
AS |
$112.58 |
$491,637 |
D/D |
(4,367) |
118,122 |
|
- |
|
Pendarvis David |
Chief Administrative Officer |
|
2019-05-03 |
4 |
OE |
$52.02 |
$227,171 |
D/D |
4,367 |
122,579 |
|
- |
|
Hollingshead James |
President, Sleep Business |
|
2019-05-01 |
4 |
AS |
$104.51 |
$167,216 |
D/D |
(1,600) |
78,857 |
|
- |
|
Hollingshead James |
President, Sleep Business |
|
2019-05-01 |
4 |
OE |
$58.24 |
$46,592 |
D/D |
800 |
80,457 |
|
- |
|
Sandercock Brett |
Chief Financial Officer |
|
2019-04-30 |
4 |
AS |
$102.98 |
$308,940 |
D/D |
(3,000) |
82,390 |
|
- |
|
Douglas Robert Andrew |
President and COO ResMed Inc. |
|
2019-04-15 |
4 |
AS |
$102.29 |
$100,040 |
I/I |
(978) |
152,357 |
|
- |
|
Douglas Robert Andrew |
President and COO ResMed Inc. |
|
2019-04-15 |
4 |
AS |
$102.29 |
$338,273 |
D/D |
(3,307) |
45,297 |
|
- |
|
Douglas Robert Andrew |
President and COO ResMed Inc. |
|
2019-04-15 |
4 |
OE |
$43.63 |
$144,284 |
D/D |
3,307 |
48,604 |
|
- |
|
Farrell Michael J. |
Chief Executive Officer |
|
2019-04-08 |
4 |
AS |
$100.82 |
$670,554 |
D/D |
(6,651) |
286,282 |
|
- |
|
Farrell Michael J. |
Chief Executive Officer |
|
2019-04-08 |
4 |
OE |
$43.63 |
$290,183 |
D/D |
6,651 |
292,933 |
|
- |
|
Pendarvis David |
Chief Administrative Officer |
|
2019-04-03 |
4 |
AS |
$105.21 |
$468,921 |
D/D |
(4,457) |
118,002 |
|
- |
|
Pendarvis David |
Chief Administrative Officer |
|
2019-04-03 |
4 |
OE |
$51.25 |
$228,421 |
D/D |
4,457 |
122,459 |
|
- |
|
Mchale Richard |
President, RC Business |
|
2019-04-02 |
4 |
AS |
$105.00 |
$2,784,915 |
D/D |
(26,523) |
23,404 |
|
- |
|
Mchale Richard |
President, RC Business |
|
2019-04-02 |
4 |
OE |
$58.24 |
$1,544,700 |
D/D |
26,523 |
45,020 |
|
- |
|
Mchale Richard |
President, RC Business |
|
2019-04-01 |
4 |
AS |
$105.05 |
$138,981 |
D/D |
(1,323) |
23,404 |
|
- |
|
Mchale Richard |
President, RC Business |
|
2019-04-01 |
4 |
OE |
$58.24 |
$77,052 |
D/D |
1,323 |
24,483 |
|
- |
|
Sandercock Brett |
Chief Financial Officer |
|
2019-04-01 |
4 |
AS |
$104.96 |
$314,880 |
D/D |
(3,000) |
85,390 |
|
- |
|
Hollingshead James |
President, Sleep Business |
|
2019-04-01 |
4 |
AS |
$104.96 |
$167,936 |
D/D |
(1,600) |
79,657 |
|
- |
|
Hollingshead James |
President, Sleep Business |
|
2019-04-01 |
4 |
OE |
$58.24 |
$46,592 |
D/D |
800 |
81,257 |
|
- |
|
Douglas Robert Andrew |
President and COO ResMed Inc. |
|
2019-03-15 |
4 |
AS |
$100.90 |
$99,992 |
I/I |
(991) |
153,335 |
|
- |
|
Douglas Robert Andrew |
President and COO ResMed Inc. |
|
2019-03-15 |
4 |
AS |
$100.90 |
$333,676 |
D/D |
(3,307) |
45,297 |
|
- |
|
1262 Records found
|
|
Page 24 of 51 |
|
|